Histologic Subtypes of Microsatellite Instability-High (MSI-H) Colorectal Adenocarcinomas (CRCs) and Their Association with Clinicopathologic Features and Prognosis

被引:0
|
作者
Agarwal, A. [1 ]
Sethi, S. [1 ]
Lin, E. [1 ]
Luthra, R. [1 ]
Rashid, A. [1 ]
Hamilton, S. R. [1 ]
Eng, C. [1 ]
Maru, D. M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
591
引用
收藏
页码:134A / 134A
页数:1
相关论文
共 50 条
  • [41] KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer.
    Le, Dung T.
    Kavan, Petr
    Kim, Tae Won
    Burge, Matthew E.
    Van Cutsem, Eric
    Hara, Hiroki
    Boland, Patrick McKay
    Van Laethem, Jean-Luc
    Geva, Ravit
    Taniguchi, Hiroya
    Crocenzi, Todd S.
    Sharma, Manish
    Atreya, Chloe Evelyn
    Diaz, Luis A.
    Liang, Li Wen
    Marinello, Patricia
    Dai, Tong
    O'Neil, Bert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] THE HUMANISTIC BURDEN OF MICROSATELLITE INSTABILITY-HIGH (MSI-H) COLORECTAL CANCER (CRC) AND METASTATIC CRC (MCRC) PATIENTS TREATED WITH SUBSEQUENT LINE THERAPY: A SYSTEMATIC REVIEW
    Kohn, C. G.
    Nguyen, E.
    Miller, J. D.
    Nwokeji, E.
    Laurie, M.
    Kamble
    Khan, T.
    Masood, A.
    Korytowsky, B.
    VALUE IN HEALTH, 2017, 20 (09) : A454 - A454
  • [43] Multiple tumor suppressor genes are 'targets' of promoter hypermethylation in microsatellite instability-high (MSI-H) sporadic colorectal cancers: New insights into the mechanism of colon carcinogenesis
    Goel, A
    Arnold, CN
    Chang, DK
    Niedzwiecki, D
    Wasserman, L
    Compton, C
    Mayer, RJ
    Bertagnolli, MM
    Boland, CR
    GASTROENTEROLOGY, 2002, 122 (04) : A16 - A16
  • [44] Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
    Goldstein, J.
    Tran, B.
    Ensor, J.
    Gibbs, P.
    Wong, H. L.
    Wong, S. F.
    Vilar, E.
    Tie, J.
    Broaddus, R.
    Kopetz, S.
    Desai, J.
    Overman, M. J.
    ANNALS OF ONCOLOGY, 2014, 25 (05) : 1032 - 1038
  • [45] Microsatellite instability-high (MSI-H) colorectal cancers with elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) signature represent a target population for immune checkpoint and DNA damaging therapies
    Tan, K. T.
    Yu, P-N.
    Chen, S-J.
    Liu, Y-T.
    Chang, S-C.
    Chen, M-H.
    ANNALS OF ONCOLOGY, 2018, 29 : 55 - 55
  • [46] Aberrant CDX2 and CK7/CK20 expression in colorectal adenocarcinomas with high-frequency microsatellite instability (MSI-H)
    Chandan, V. S.
    Abraham, S. C.
    Halling, K.
    Wu, T-T
    MODERN PATHOLOGY, 2008, 21 : 114A - 114A
  • [47] Aberrant CDX2 and CK7/CK20 expression in colorectal adenocarcinomas with high-frequency microsatellite instability (MSI-H)
    Chandan, V. S.
    Abraham, S. C.
    Halling, K.
    Wu, T-T
    LABORATORY INVESTIGATION, 2008, 88 : 114A - 114A
  • [48] Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies
    Bouziane, S. Ziane
    Mans, L.
    Bucalau, A. -M.
    Demetter, P.
    Pezzullo, M.
    Andre, C.
    Loi, P.
    Navez, J.
    Marcelis, L.
    Puleo, F.
    Charette, N.
    Closset, J.
    Van Laethem, J. L.
    EUROPEAN JOURNAL OF CANCER, 2024, 206
  • [49] Clinicopathological and genomic characteristics of DNA Mismatch Repair-Deficient (dMMR) and microsatellite instability-high (MSI-H) resected gastric adenocarcinoma
    Zhou, J.
    Liang, B.
    Yin, M.
    Zhang, H.
    Liu, F.
    Dong, L.
    Zhang, B.
    Xu, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S921 - S922
  • [50] Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review
    Gim, Gahyun
    Kim, Yeseul
    Park, Yeonggyeong
    Kim, Min Jeong
    Nam, Myungwoo
    Yang, Woojung
    Duarte, Samantha E.
    Jung, Chan Mi
    Vagia, Elena
    Viveiros, Pedro
    Chae, Young Kwang
    ONCOLOGIST, 2022, 27 (07): : 525 - 531